Showing results (401-410 of 583) with videos related to

Sort By:
Pageof 59
Anticancer Research|April 12, 2015
Hyperthermia combined with chemotherapy for patients with residual or recurrent oesophageal cancer after definitive chemoradiotherapySho Nishimura, Hiroshi Saeki, Tomonori Nakanoko, et al.
Digestive Endoscopy : Official Journal of the Japan Gastroenterological Endoscopy Society|January 10, 2025
Traction-assisted endoscopic ultrasound-guided fine-needle biopsy using the clip-with-thread method for small gastric subepithelial lesions: Randomized controlled trial (with video)Yosuke Minoda, Yusuke Suzuki, Haruei Ogino, et al.
International Journal of Clinical Oncology|May 21, 2017
A prospective study of XELIRI plus bevacizumab as a first-line therapy in Japanese patients with unresectable or recurrent colorectal cancer (KSCC1101)Koji Ando, Yasunori Emi, Toyokuni Suenaga, et al.
International Journal of Clinical Oncology|May 26, 2026
Changes in plasma cfDNA ERBB2 copy number reflect prognosis in HER2-positive gastric cancer: a correlative analysis of the KSCC-TROX A2 studyYuki Shin, Akitaka Makiyama, Teppei Yamada, et al.
Surgical Case Reports|October 8, 2016
Development of fistula between esophagogastric anastomotic site and cartilage portion of trachea after subtotal esophagectomy for cervical esophageal cancer: a case reportDaisuke Taniguchi, Hiroshi Saeki, Yuichiro Nakashima, et al.
Annals of Surgical Oncology|February 23, 2017
Prognostic Significance of Sarcopenia in Patients with Esophagogastric Junction Cancer or Upper Gastric CancerKensuke Kudou, Hiroshi Saeki, Yuichiro Nakashima, et al.
Cancer Medicine|March 26, 2021
Cytolytic activity score as a biomarker for antitumor immunity and clinical outcome in patients with gastric cancerQingjiang Hu, Kentaro Nonaka, Hiroaki Wakiyama, et al.
International Journal of Clinical Oncology|January 10, 2016
S-1 and irinotecan plus bevacizumab as second-line chemotherapy for patients with oxaliplatin-refractory metastatic colorectal cancer: a multicenter phase II study in Japan (KSCC1102)Yuji Miyamoto, Akihito Tsuji, Hiroaki Tanioka, et al.
International Journal of Clinical Oncology|November 16, 2017
Correction to: S-1 and irinotecan plus bevacizumab as second-line chemotherapy for patients with oxaliplatin-refractory metastatic colorectal cancer: a multicenter phase II study in Japan (KSCC1102)Yuji Miyamoto, Akihito Tsuji, Hiroaki Tanioka, et al.
Plos One|June 30, 2020
Identification of characteristic compounds of moderate volatility in breast cancer cell linesMitsuru Tanaka, Chung Hsuan, Masataka Oeki, et al.
Pageof 59